CG Oncology (CGON) Current Assets (2023 - 2026)

CG Oncology has reported Current Assets for 4 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 57.18% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 57.18% YoY), and the FY2025 full-year result was $759.5 million, up 0.7% from the prior year.
• Current Assets for Q1 2026 stood at $1.1 billion, up from $759.5 million in the prior quarter.
• The five-year high for Current Assets was $1.1 billion in Q1 2026, with the low at $194.1 million in Q4 2023.
• Historically, Current Assets has averaged $657.5 million across 4 years, with a median of $684.4 million in 2025.
• Annual changes were most pronounced in 2024 — Current Assets jumped 288.52% — and 2025, when it increased 0.7%.
• CG Oncology's Current Assets stood at $194.1 million in 2023, then jumped by 288.52% to $754.2 million in 2024, then grew by 0.7% to $759.5 million in 2025, then surged by 45.12% to $1.1 billion in 2026.
• The last three Current Assets figures came in at $1.1 billion (Q1 2026), $759.5 million (Q4 2025), and $695.8 million (Q3 2025), per Business Quant data.